WB 006
Alternative Names: WB-006Latest Information Update: 05 Feb 2025
At a glance
- Originator Whitecap Biosciences
- Developer Bausch & Lomb
- Class Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Dry macular degeneration